Raffi Asadorian
2015 - Amyris
In 2015, Raffi Asadorian earned a total compensation of $1.3M as Chief Financial Officer at Amyris.
Compensation breakdown
| Non-Equity Incentive Plan | $68,362 |
|---|---|
| Option Awards | $340,890 |
| Salary | $445,096 |
| Stock Awards | $350,000 |
| Other | $53,842 |
| Total | $1,258,190 |
Asadorian received $445.1K in salary, accounting for 35% of the total pay in 2015.
Asadorian also received $68.4K in non-equity incentive plan, $340.9K in option awards, $350K in stock awards and $53.8K in other compensation.
Rankings
In 2015, Raffi Asadorian's compensation ranked 6,817th out of 13,638 executives tracked by ExecPay. In other words, Asadorian earned more than 50.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,817 out of 13,638 | 50th |
Division Manufacturing | 2,567 out of 5,190 | 51st |
Major group Chemicals And Allied Products | 925 out of 1,854 | 50th |
Industry group Industrial Organic Chemicals | 22 out of 73 | 70th |
Source: SEC filing on April 27, 2017.
Asadorian's colleagues
We found five more compensation records of executives who worked with Raffi Asadorian at Amyris in 2015.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019